Exemestane Tablets

BRITISH DRAGON EXEMESTANE

Exemestane Tablets by British Dragon is an oral medication containing Exemestane as the active substance. Each tablet typically provides 25 mg of Exemestane. Exemestane is classified as an aromatase inhibitor, playing a crucial role in hormone-responsive breast cancer treatment.

DRUG COMPOSITION

Each tablet of Exemestane contains 25 mg of Exemestane.

PHARMACEUTICAL FORM

Exemestane is formulated in tablet form for convenient oral administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents; ATC code: L02BG06.

PHARMACOLOGICAL PROPERTIES

Exemestane is an aromatase inhibitor that acts by reducing estrogen levels in postmenopausal women. It inhibits the conversion of androgens to estrogens, which is crucial in hormone-receptor-positive breast cancer.

PROFILE

• Chemical name: (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
• Chemical formula: C20H24O2
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: 9 hours
• Recommended dosage: 12.5-25 mg/day
• Acne: no
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: no
• Aromatization: no

THERAPEUTICAL INDICATIONS

Exemestane is primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women, both in the adjuvant setting and for metastatic disease.

DOSES AND METHOD OF ADMINISTRATION

The dosage and administration of Exemestane are individualized based on the specific needs and medical condition of the patient. It is generally taken orally once daily with food.

CYCLE/STACKING

Solo cycle:

• Exemestane is often used as a standalone therapy for postmenopausal women with estrogen receptor-positive breast cancer.

Cutting cycle:

• Exemestane is commonly used in cutting cycles, especially when dealing with estrogen-related side effects from other compounds.

Bulking cycle:

• Exemestane may be included in bulking cycles to manage estrogen levels when using aromatizable anabolic steroids.

POST CYCLE THERAPY

Exemestane is sometimes employed in post-cycle therapy (PCT) to prevent estrogen rebound after the use of aromatizable steroids. The duration and dosage may vary.

SIDE EFFECTS

Common side effects include hot flashes, fatigue, and joint pain. Serious side effects are rare but may include bone density reduction.

CONTRAINDICATIONS

Exemestane is contraindicated in individuals with hypersensitivity to the drug. It should not be used in premenopausal women or in those with severe hepatic impairment.

OVERDOSE

There is limited information on the effects of overdose. In case of overdose, seek medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Patients with a history of osteoporosis or other bone-related issues should be monitored closely. Regular bone density assessments may be recommended.

INTERACTIONS WITH OTHER DRUGS

Exemestane may interact with certain medications, and patients should inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

25 mg per tablet, 50 tablets in sachet.

STORAGE

Store Exemestane in a cool, dry place, protected from light.

LEGAL STATUS

Exemestane is a prescription medication and is subject to legal regulations.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

British Dragon
Europe

EXTERNAL LINKS

• Exemestane Wiki, wikipedia.org
• Exemestane: Uses, Dosage, Side Effects, Warnings, drugs.com
• Exemestane Oral: Uses, Side Effects, Interactions, Pictures, webmd.com.